XML 48 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
Equity (Details) - USD ($)
 1 Months Ended 2 Months Ended 6 Months Ended 12 Months Ended
Oct. 03, 2016
May 06, 2016
Mar. 21, 2016
Feb. 08, 2016
Feb. 28, 2017
Aug. 26, 2016
Feb. 17, 2016
Sep. 30, 2015
Mar. 31, 2017
Sep. 30, 2016
Mar. 31, 2016
Dec. 29, 2015
Oct. 30, 2015
Equity (Textual)                          
Common stock, authorized     360,000,000         360,000,000 360,000,000 360,000,000      
Common stock, par value     $ 0.001         $ 0.001 $ 0.001 $ 0.001      
Description of forward split     1 to 3:141                    
Subscription receivable               $ 350,000       $ 350,000
Issuance of common shares         $ 5,850,000     51,958   3,250,000      
Issuance of common shares, shares         2,925,000                
Purchase price per share         $ 2.0                
Payment of American BriVision               $ 22,517 $ 950,000 $ 6,500,000      
Consulting agreement, description The Company entered into a Consulting Agreement with Kazunori Kameyama ("Kameyama") for the provision of services related to the clinical trials and other administrative work, public relation work, capital raising, trip coordination, In consideration for providing such services, the Company agreed to indemnify the consultant in an amount of $150 per hour in cash up to $3,000 per month, and issue to Kameyama the Company's common stock at $1.00 per share for any amount exceeding $3,000. The Company's stocks will be calculated and issued in December every year. The contract will be terminated on September 30, 2017. For the six months ended on March 31, 2017, the Company recognized (as appropriate relative to the periods and manner that the Company would recognize cash payments under the same arrangement) the cost of the appropriate number of the 1,688 shares at the current fair value as of December 31, 2016 and March 31, 2017. The stock-based compensation related to this consulting agreement was $3,376 for the six months ended on March 31, 2017.                        
2016 Plan [Member]                          
Equity (Textual)                          
Common stock issued pre-stock split             50,000            
Common stock issued post-stock split             157,050            
Biolite Inc [Member]                          
Equity (Textual)                          
Common stock, par value           $ 0.001              
Issuance of common shares           $ 1,468,750              
Purchase price per share           $ 1.60              
Net proceeds from offering           $ 2,350,000              
Share Exchange Agreement [Member]                          
Equity (Textual)                          
Common stock issued pre-stock split       52,336,000                  
Common stock issued post-stock split       164,387,376                  
Share Exchange Agreement 1 [Member]                          
Equity (Textual)                          
Common stock issued pre-stock split       52,936,583                  
Common stock issued post-stock split       166,273,921                  
Share Exchange Agreement 2 [Member]                          
Equity (Textual)                          
Common stock issued pre-stock split       51,945,225                  
Common stock issued post-stock split       163,159,952                  
Percentage of common shares issued and outstanding       79.70%                  
Percentage of issued share capital       100.00%                  
Share Exchange Agreement 3 [Member]                          
Equity (Textual)                          
Common stock issued pre-stock split       52,936,583                  
Common stock issued post-stock split       166,273,921                  
Exchange ratio       0.2536-for-1                  
Share Exchange Agreement 4 [Member]                          
Equity (Textual)                          
Common stock issued pre-stock split       65,431,144                  
Common stock issued post-stock split       205,519,223                  
Percentage of common shares issued and outstanding       79.70%                  
Collaborative Arrangement [Member]                          
Equity (Textual)                          
Issuance of common shares   $ 900,000                      
Issuance of common shares, shares   562,500                      
Share price   $ 1.60                      
Payment of American BriVision           $ 100,000,000           $ 100,000,000  
Percentage of payments under collaborative agreement                 3.50%        
Collaborative Arrangement One [Member]                          
Equity (Textual)                          
Issuance of common shares         $ 5,850,000                
Issuance of common shares, shares         2,925,000                
Share price         $ 2.0                
Total payment upon first IND submission                 $ 6,500,000   $ 6,500,000    
Percentage of payments under collaborative agreement                 6.50%        
Remitted amount         $ 650,000